Glutamate agents in the treatment of mental disorders
Methods of treating mental disorders, including anxiety disorders such as obsessive-compulsive disorder, are provided. The methods comprise administering an effective amount of a glutamate modulator to an individual in need thereof. Also provided are methods of enhancing the activity of a serotonin reuptake inhibitor (SRI) comprising co-administering a glutamate modulator and a serotonin reuptake inhibitor. Pharmaceutical composition comprising a serotonin reuptake inhibitor and a glutamate modulator are also provided.
1. A method of treating a mental disorder in an individual in need thereof comprising administering to said individual a pharmaceutical composition comprising an effective amount of riluzole alone for treating said mental disorder, wherein said mental disorder is social anxiety disorder or panic disorder.
2. The method according to claim 1 wherein said mental disorder is social anxiety disorder.
3. The method according to claim 1 wherein said mental disorder is panic disorder.
4. The method according to claim 1 wherein said composition is administered once daily.
5. The method according to claim 2 wherein said composition is administered once daily.
6. The method according to claim 3 wherein said composition is administered once daily.